| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.21 | 1e-07 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.18 | 6e-06 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.21 | 0.0003 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0008 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |